z-logo
open-access-imgOpen Access
Obesity and Breast Cancer: The Roles of Peroxisome Proliferator‐Activated Receptor‐γ and Plasminogen Activator Inhibitor‐1
Author(s) -
Jennifer C. Carter,
Frank Church
Publication year - 2009
Publication title -
ppar research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 49
eISSN - 1687-4765
pISSN - 1687-4757
DOI - 10.1155/2009/345320
Subject(s) - adipokine , breast cancer , plasminogen activator inhibitor 1 , medicine , adipose tissue , obesity , peroxisome proliferator activated receptor , plasminogen activator , adipogenesis , cancer , endocrinology , cancer research , mediator , receptor , oncology , leptin
Breast cancer is the most prominent cancer among females in the United States. There are a number of risk factors associated with development of breast cancer, including consumption of a high-fat diet and obesity. Plasminogen activator inhibitor-1 (PAI-1) is a cytokine upregulated in obesity whose expression is correlated with a poor prognosis in breast cancer. As a key mediator of adipogenesis and regulator of adipokine production, peroxisome proliferator-activated receptor- γ (PPAR- γ ) is involved in PAI-1 expression from adipose tissue. We summarize the current knowledge linking PPAR- γ and PAI-1 expression to high-fat diet and obesity in the risk of breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom